Physician profile
Collin Durham
NPI 1194288597
$371.55
in general payments reported to CMS, 2019-2025
7 companies · $56.11 in 2025
The $56.11 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.55 · 2022: $70.71 · 2023: $175 · 2024: $58.58 · 2025: $56.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279 · Education: $10.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.76 |
| Education | $10.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.91 | 2023-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $66.78 | 2023-2025 | Zerbaxa, Recarbrio, Dificid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.85 | 2021-2023 | Spevigo, Jardiance |
| Boston Scientific Corporation | $55.23 | 2022 | |
| Gilead Sciences, INC. | $25.16 | 2023 | Veklury |
| Novo Nordisk INC | $18.14 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Durham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.